Indivior PLC Ordinary Share (INDV)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
944.50p
Buy
947.50p
36.50p (+4.02%)
Indivior PLC is a US-based specialty and generic drug manufacturin eneric drug manufacturg company. The firm develops, manufactures, and sells prescription drugs that are mainly based on buprenorphine for treatment of opioid dependence.
Prices updated at 30 May 2025, 17:46 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
| Year | Gross margin (%) | Operating margin (%) | Net margin (%) | EBITDA margin (%) | EBITDA |
|---|---|---|---|---|---|
| 2024 | 80.56 | 19.19 | 0.17 | 7.07 | 84m |
| 2023 | 84.08 | 22.23 | -11.80 | -9.06 | -99m |
| 2022 | 83.24 | 23.86 | -4.88 | -5.11 | -46m |
| 2021 | 83.94 | 22.88 | 25.92 | 30.09 | 238m |
| 2020 | 85.01 | -24.11 | -22.87 | -19.01 | -123m |
| 2019 | 82.17 | 22.68 | 17.07 | 29.30 | 230m |
| 2018 | 87.26 | 31.44 | 27.36 | 32.04 | 322m |
| 2017 | 90.48 | 17.66 | 5.31 | 17.11 | 187m |
| 2016 | 89.89 | 14.08 | 3.31 | 14.74 | 156m |
Valuation data table
| Year | Price / Sales | Price earnings | Price / Cash flow |
|---|---|---|---|
| 2025 | 1.42 | - | 11.20 |
| 2024 | 1.49 | - | - |
| 2023 | 2.06 | - | - |
| 2022 | 1.56 | 4.76 | 7.62 |
| 2021 | 5.70 | 3.77 | 37.31 |
| 2020 | 1.91 | - | - |
| 2019 | 0.43 | 1.76 | 1.93 |
| 2018 | 1.03 | 10.18 | 3.87 |
| 2017 | 3.77 | 14.44 | 11.39 |
| 2016 | 2.57 | - | 8.27 |
| 2015 | 1.94 | 7.52 | 6.71 |
Price/Forward earnings (YTD)
-
Returns
Debt profile
Returns data table
| Year | Return on assets (%) | Return on equity (%) | Return on invested capital (%) |
|---|---|---|---|
| 2024 | 0.13 | - | - |
| 2023 | -7.31 | - | - |
| 2022 | -2.44 | -34.65 | -9.22 |
| 2021 | 12.19 | 143.86 | 52.16 |
| 2020 | -9.30 | -101.72 | -30.71 |
| 2019 | 8.38 | 97.45 | 32.76 |
| 2018 | 18.39 | - | - |
| 2017 | 4.37 | - | - |
| 2016 | 3.26 | - | - |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | - |
| 2023 | - |
| 2022 | 34.69 |
| 2021 | 9.02 |
| 2020 | 18.67 |
| 2019 | 7.90 |
| 2018 | 23.44 |
| 2017 | - |
| 2016 | - |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
